Replies to post #757874 on NorthWest Biotherapeutics Inc (NWBO)

[branster]

X, yes even using Grade B labs we could get close to 1000 per year just at advent or 200 million per year gross (double shifts).

[Investor082]

They wont be able to generate more than $15M in annual revenue post UK approval for at least a couple of years. It will be easy money for shorts again to establish another short bet at any UK approval spike we may get. Endless dilution will continue.